Past Presentation

Sublocade | September 2, 2021

Date of Presentation: September 2, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder ECHO Program  

Keywords: #sublocade  #SUD treatment  

In this presentation, Dr. Jessica Gregg discusses the pharmacodynamics of the medication Sublocade and its use as one of the tools in treatment of Substance Use Disorders.


Presenter Bio:

Dr. Jessica Gregg

Jessica Gregg, MD, PhD, received her undergraduate degree at Stanford University, her medical degree at the University of New Mexico, and a PhD in Medical Anthropology at Emory University. She began her medical career in primary care at Oregon Health and Science University (OHSU), where she co-founded the OHSU Department of Medicine’s Social Medicine curriculum in partnership with City Central Concern, a non-profit caring for individuals struggling with lack of housing and substance use disorders. She subsequently became the medical director for Central City Concern’s Hooper Detoxification and Stabilization Center, and eventually assumed the role of Senior Medical Director for Substance Use Disorder Services for the agency. She subsequently developed the HRBR clinic at OHSU, a low-threshold buprenorphine clinic, and in 2021, she became Chief Medical Officer for De Paul Treatment Centers in Portland, Oregon.

Date added: September 16, 2021

  • Add to myECHO